The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study

Charidimou, Andreas; Boulouis, Grégoire; P. Frosch, Matthew; Baron, Jean-Claude; Pasi, Marco; François Albucher, Jean; Banerjee, Gargi; Barbato, Carmen; Bonneville, Fabrice; Brandner, Sebastian; Calvière, Lionel; Caparros, François; Casolla, Barbara; Cordonnier, Charlotte; Delisle, Marie‐Bernadette; Deramecourt, Vincent; Dichgans, Martin; Gökçal, Elif; Herms, Jochen; Hernández‐Guillamón, Mar; Rolf Jäger, Hans; Jaunmuktane, Zane; Linn, Jennifer; Martínez‐Ramírez, Sergi; Martínez‐Sáez, Elena; Mawrin, Christian; Montaner, Joan; Moulin, Solène; Olivot, Jean‐Marc; Piazza, Fabrizio; Puy, Laurent; Raposo, Nicolas; Rodrigues, Mark; Roeber, Sigrun; R. Romero, José; Samarasekera, Neshika; A. Schneider, Julie; Schreiber, Stefanie; Schreiber, Frank; Schwall, Corentin; Smith, Colin; Szalárdy, Levente; Varlet, Pascale; Viguier, Alain; M. Wardlaw, Joanna; D. Warren, Andrew; A. Wollenweber, Frank; Zedde, Marialuisa; A. van Buchem, Mark; Edip Gurol, M.; Viswanathan, Anand; Al‐Shahi Salman, Rustam; E. Smith, Eric; J. Werring, David; M. Greenberg, Steven

doi:10.1016/s1474-4422(22)00208-3

Public

The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study

Published in The Lancet Neurology • Jul 13, 2022

Authors:

Andreas Charidimou

Grégoire Boulouis

Matthew P. Frosch

Abstract

BACKGROUND: Cerebral amyloid angiopathy (CAA) is an age-related small vessel disease, characterised pathologically by progressive deposition of amyloid β in the cerebrovascular wall. The Boston criteria are used worldwide for the in-vivo diagnosis of CAA but have not been updated since 2010, before ...

Subject

Cerebral amyloid angiopathy

Neuropathology

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!